BREZTRI 9 ug/1

BREZTRI 9 ug/1 is a combination inhaler containing budesonide, glycopyrrolate, and formoterol fumarate. It is used for respiratory conditions requiring multiple therapies. This metered aerosol provides targeted delivery for effective management.

BREZTRI 9 ug/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This combination inhaler targets inflammation and bronchoconstriction, helping to improve breathing and reduce symptoms. It is often prescribed for individuals who require both a corticosteroid and a bronchodilator. The inhaler is designed for respiratory conditions that benefit from a multi-therapy approach.

Common effects of BREZTRI 9 ug/1 may include throat irritation, hoarseness, and dry mouth. Some users might experience headaches or tremors. These effects are generally mild and temporary. It is important to follow the prescribed usage to minimize potential discomfort.

BREZTRI 9 ug/1 should be used as directed by a healthcare professional. It is important to rinse your mouth after each use to reduce the risk of oral thrush. Patients with certain medical conditions, such as heart disease or glaucoma, should discuss their health status with their doctor before using this inhaler. Always store the inhaler properly to maintain its effectiveness.

BREZTRI 9 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking. Alcohol and other respiratory medications should be used with caution. Always consult your doctor before starting any new treatment.